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The standard microtiter plate is 
undergoing a makeover, with any 
number of companies squeezing 384, 
1536 or even 6144 wells into the 
space that once held just 96 wells. 
But for Illumina Inc. (San Diego, 
California) these increases in capacity 
are almost comically small. Illumina 
is crowding wells together at a 
density of twenty million per square 
centimeter, with each well 
individually addressable by light. 
What makes it all possible is 
optical fibers. A one-step acid 
treatment of a commercial optical 
fiber turns the fiber into an array of 
microscopic wells. The cladding of 
the fibers resists acid treatment, even 
as the fiber cores are etched away to 
make the wells. Each well can then 
be viewed at the other end of the 
fiber using a microscope with a 
charge-coupled device (CCD). 
Coded beads - synthesized in 
bulk in large pools and then randomly 
distributed into the wells - act as the 
sensors. “We’ve exchanged the very 
difficult problem of synthesizing 
things on a very small scale with the 
more tractable problem of decoding,” 
says Illumina founder and chief 
scientific officer Tony Czarnik. Now 
the company has to decide what, of all 
the things that could be detected by a 
bead-based sensor, should be the 
focus of the company. 
Sensing with optical fibers 
Illumina is based on the work of 
David Walt (Tufts University, 
Medford, Massachusetts). Initially 
Walt used single-core fibers to transmit 
the optical readout of a chemical 
event. Based on this technology, Walt 
founded Optical Sensors, Inc. 
(Minneapolis, Minnesota), which 
makes a group of three fibers to 
measure blood pH, carbon dioxide 
and oxygen levels without the need to 
draw blood. Ariano Technologies, Inc. 
(Cambridge, Massachusetts) uses the 
fibers to detect hydrocarbon vapors 
around leaking gas storage tanks, and 
YSOS Inc. (Yellow Springs, Ohio) 
does bioprocess monitoring during 
the production of drugs, vaccines, 
food and beverages. 
The next step for Walt was sensor 
arrays. By shining light through a 
single fiber in a bundle, he could use 
photoactivatable groups to attach 
sensors to a small area on the bundle 
tip. Up to 30 different sensors could 
be localized to different areas on a 
single bundle tip. 
That density is still not high 
enough for what Illumina has in 
mind. The path to the Illumina 
arrays began with a modest paper in 
a 1996 issue of Chemistry of Materials. 
The paper reported the chemical 
etching of fiber tips to create 
optically wired wells. The next step 
was to place plastic microspheres 
(and the chemicals attached to them) 
in each well. Happily, approximately 
96% of the wells could be filled by 
pipetting a suspension of the 
microspheres onto the end of the 
bundle and allowing the suspension 
to dry (Figure 1). “When my student 
Karri Michael showed me the 
micrographs [of the beads in the 
wells], our eyes were bugging out of 
our heads,” says Walt. “We were 
amazed that these things were 
working themselves into the wells.” 
Before Walt contacted the 
venture capitalists there was one 
more problem to face. “We just had 
no idea what the things were good 
for,” says Walt. “We sat on the result 
for months and months.” 
The simple regimen of pipette, 
settle, and dry was great for getting 
the beads into the wells, but it left the 
researchers with no clues about the 
location of different beads in the array. 
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Figure 1 
Beads in femtowells. This false-color image is 
based on an atomic force micrograph of 
-3.6~pm-diameter wells each containing a 
single 3.1 -pm-diameter microsphere. 
Reprinted with permission from Anal. Chem., 
1998, 70, 1242-l 248. Copyright 1998 
American Chemical Society. 
Walt’s collaboration with W. Clark 
Still (Columbia University, New York) 
inspired him with at least a temporary 
fix to the problem. Still’s chemical 
tags identify the beads used in 
combinatorial chemistry; a similar set 
of tags that generate an optical 
readout would allow Walt to locate 
every one of his microspheres. As 
described in a 1998 paper in Analytical 
Chemistry, Walt soaked each bead 
type, with its sensor attached, in a 
mixture of dyes of a particular identity 
and concentration. By correlating two 
optical readouts - one from the dye 
mixture and the other from the 
binding of molecules such as avidin 
and biotin to the various sensors - 
the researchers found that the system 
could differentiate six different types 
of beads with 92% accuracy. 
The founding of a company 
With the Analytical Chemistry paper 
came the birth of Illumina, which 
opened for business in June 1998. 
Czarnik arrived from IRORI (see 
Chem. BioL 5, R39-R40) and Mark 
Chee from Affymetrix (see Chem. 
Biol. 4, 157-158). 
“When I joined the company, we 
identified, I think correctly, that the 
method for relining the array was 
largely developmental,” says Czarnik. 
“We didn’t have a lot of discovery - 
we were assembling from known 
components. Where the invention part 
of the company lies is in the encoding.” 
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Figure 2 
Detection of benzene by an optical nose. The 
figure shows 35 sequential images of the 
bundle of optical fibers that make up the 
optical nose. Each fiber has a different 
sensing chemical attached; these chemicals 
differ in the kinetics of their interaction with 
benzene and the effect of that interaction on 
their emission spectrum. The sum of all the 
changes in the different images is a 
molecular signature for benzene, which 
allows it to be differentiated from many other 
chemicals. In this experiment, benzene is 
applied between frames 4 and 19, with the 
entire set of images covering less than nine 
seconds. Image courtesy of Todd Dickinson, 
John Kauer, and David Walt. Reprinted with 
permission from Elsevier Science. 
Walt’s encoding solution works for 
a few different sensors, but it soon 
runs into problems with the overlap of 
multiple similar spectra. “This,” says 
Czarnik, “is the intellectual nucleus 
of the company - how you can 
reliably encode thousands of beads in 
a robust way.” Illumina is hoping that 
the answer, for both the thousands of 
beads in an oligonucleotide array and 
the millions of beads in a 
combinatorial chemistry array, is 
buried in paperwork now at the US 
patent office. “We’ve got solutions and 
they are part of patent applications,” 
says Czarnik. “The proof-of-concept 
experiments for our first scheme have 
been completed successfully.” 
What is it good for? 
Illumina’s strength is the simplicity 
of array construction. “We are able to 
create something with very fine 
structure with only bulk processes,” 
says Czarnik. “And the technology is 
very scalable. The method for 
creating 250,000 wells on a fiber is 
the same as that for creating one.” 
But who will buy the arrays, and 
what will they use them for? Illumina 
is initially focusing on single 
nucleotide polymorphism genotyping, 
and may move on to expression 
analysis. “I think the genomics 
application absolutely needs to be 
pursued in the short term,” says Walt. 
“The number of companies interested 
in functional genomics or expression 
patterns is way up, and people are 
fixing on a platform. So if we are not 
out there now showing what we have, 
there won’t be a market in a couple of 
years. It has to be a quick process.” 
One of Illumina’s primary 
competitors will be Affymetrix, who 
have an issued patent covering 
expression analysis using any type of 
high density array. “Affymetrix is the 
leader in the DNA array synthesis 
world,” admits Czarnik. But, he says, 
“we wouldn’t even have begun our 
company if we weren’t confident of 
our ability to practice.” Illumina has 
the exclusive license to Walt’s 
technology, which Walt claims will 
prove superior. “The small size of 
the array and the amount of 
information you can get from the 
array is tremendous relative to the 
other platforms,” he says. 
“[Illumina’s customers] will be able 
to capture any lost time just because 
of the high-throughput capabilities.” 
The next priority will be drug 
discovery: testing small molecules 
attached to the beads against protein 
targets. Antibodies on the beads could 
be used for proteomics or diagnostics. 
The science-fiction side of the 
company is the optical-nose project 
(Figure 2). In collaboration with Tufts 
neuroscience professor John Kauer, 
Walt has been interested for several 
years in using optical fibers and fancy 
pattern recognition software to mimic 
the way that smells are detected by 
the nose and decoded by the brain. As 
in the nose, the fiber system 
recognizes patterns of binding 
interactions, rather than relying on 
specific binding events between one 
analyte and one sensor. Walt has used 
the system to detect the residue of 
explosives left on the outside of 
landmines (what he calls “the needle 
in a haystack problem”), and Illumina 
may develop it for quality control in 
industrial settings. But eventually Walt 
envisions a consumer product that 
could act as a smoke, gas and carbon 
monoxide detector, then tell its user if 
last week’s chicken is off. Preventing a 
Salmonella infection, and finding the 
drugs to treat it, may both come down 
to the same bundle of optical fibers. 
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